Selected publications
Please see a list of selected publications below.
Isherwood C.M., van der Veen D.R., Hassanin H., Skene D.J., Johnston J.D. 鈥楬uman glucose rhythms and subjective hunger anticipate meal timing鈥�. Current Biology (2023). E-pub ahead of print. DOI:
Szubert A.J., Pollock K.M., Cheeseman H.M., Alagaratnam J., Bern H., Bird O., and Boffito M., Byrne R., Cole T., Cosgrove C. A. and Faust S. N., Fidler S., Galiza E., Hassanin H., and Kalyan M., and Libri V., McFarlane L. R., Milinkovic A., O鈥橦ara J., Owen D. R., Owens D., Pacurar M., Rampling T., Skene S., Winston A., Woolley J.,Yim Y. T.N, Dunn D. T., McCormack S., Shattock R.J., 'COVAC1 Phase 2a Expanded Safety and Immunogenicity Study of a Self-Amplifying RNA Vaccine Against SARS-CoV-2.' Available at SSRN: or
Lazarus, R., Querton, B., Corbic Ramljak, I., Dewasthaly, S., Jaramillo, J. C., Dubischar, K., Krammer, M., Weisova, P., Hochreiter, R., Eder-Lingelbach, S., Taucher, C., Finn A.; Valneva phase 3 trial group* (BethuneC., BoffitoM., 鈥︹��., Hana Hassanin, Heath P., 鈥�.鈥�.. Thompson E., Torku D.). (2022). 'Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial.' The Lancet Infectious Diseases.
Revell V.L., Della Monica C., Mendis J., Hassanin H., Halter R.J., Chaplan S.R., Dijk D.J. 鈥�.鈥� Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2021-10, DOI: 10.1038/s41386-021-01175-3
Win Z., Weiner 3rd J., Listanco A., Patel N., Sharma R., Greenwood A., Maertzdorf J., Mollenkopf H-J., Pizzoferro K., Cole T, Bodinham C.L., Kaufmann S.H.E., Denoel P., Del Giudice G. and Lewis D.J.M. (2021) 鈥樷��, Front. Immunol, 11:613496, doi: 10.3389/fimmu.2020.613496
Pollock K.M., Cheeseman H.M., Szubert A.J., Libri V., Boffito M., Owen D., Bern H., O鈥橦ara J., McFarlane L., Lemm N., McKay P.F., Rampling T, Yim Y.T.N., Milinkovic A., Kingsley C., Cole T., Fagerbrink S., Aban M., Tanaka M., Mehdipour S., Robbins A., Budd W., Faust S. N., Hassanin H., Cosgrove C.A., Winston A., Fidler S., Dunn D., Mccormack S., Shattock R.J. (2021) 鈥樷�� SSRN Electronic Journal.
Weiner J., Lewis D.J.M., Maertzdorf J., Mollenkopf H.J., Bodinham C., Pizzoferro K., Linley C., Greenwood A., Mantovani A., Bottazzi B., Denoel P., Leroux-Roels G., Kester K.E., Jonsdottir I., van den Berg R., Kaufmann S.H.E., Del Giudice G. (2019) 鈥樷��,鈥�Sci Rep, 2019;9(1):20362.
Priddy F., Lewis D., Gelderblom H., Hassanin H., Streatfield C., Labranche C., Hare J., Cox J., & Dally L., Bendel D., Montefiori D., Sayeed E., Ackland J., Gilmour J., Schnepp B., Wright J., Johnson P. (2019) 鈥樷��, The Lancet HIV; 6 (4), pp. e230-e239
Hassanin H., Serba S., Schmidt J., Maerten A. (2019) 鈥樷��, Clinical and experimental Immunology, [online] 158(1), pp.125-132
de Wolf A.C.M.T., van Aalst S., Ludwig I.S., Bodinham C.L., Lewis D.J., van der Zee R., et al. (2017) 鈥楻egulatory T cell frequencies and phenotypes following anti-viral vaccination鈥�, PLoS ONE, 12(6), p.e0179942.
Elhmouzi-Younes J., Palgen J., Tchitchek N., Delandre S., Namet I., Bodinham C.L., Pizzoferro K., Lewis D.J.M, Le Grand R., Cosma A. & Beignon A., (2017). 鈥樷��, Cytometry Part A, 91(10), pp.969鈥�982.
Leeder J., Glaister M., Pizzoferro K., Dawson J., & Pedlar C. (2012). 鈥�.鈥�, J Sports Sci, 2012;30(6), pp.541-545.
Plaskota M., Lucas C., Evans R. & Cook K., Pizzoferro K., Saini T. (2012). 鈥樷��, International Journal of Palliative Nursing; 18(2), pp.69-75.
McDonald K. [Pizzoferro K], Trick, L., Boyle J. (2008). 鈥樷��, Human Psychopharmacology: Clinical and Experimental; 23, pp.555鈥�570.